Top Markets
#1 QuantixAI QuantixAI +105.36%
#2 龙虾 (Lobster) 龙虾 (Lobster) +63.03%
#3 MetaDAO MetaDAO +28.63%
#4 Pons Pons +28.12%
#5 Rain Rain +23.09%
#6 Bedrock Bedrock +20.96%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +17.95%
#8 Ontology Gas Ontology Gas +17.34%
#9 Prom Prom +16.62%
#10 Humanity Humanity +14.86%
Coin of the day
QuantixAI QuantixAI
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Peringkat dalam Saham #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Harga Saham
$27.75
Kapitalisasi Pasar
$7.84B
Perubahan (1 hari)
6.21%
Perubahan (1 tahun)
-27.88%
Negara
US
Perdagangan Caris Life Sciences, Inc. (CAI)

Kategori

Healthcare
Laba untuk Caris Life Sciences, Inc. (CAI)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Caris Life Sciences, Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Caris Life Sciences, Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH